Skip to main content
Clinical Trials/DRKS00021242
DRKS00021242
Completed
未知

Cortico-spinal interactions underlying pain and pain modulation

niversitätsklinikum Hamburg-Eppendorf0 sites92 target enrollmentApril 8, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
eural encoding of opioid-induced analgesia
Sponsor
niversitätsklinikum Hamburg-Eppendorf
Enrollment
92
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2020
End Date
October 31, 2016
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • Healthy, fully competent, male gender, ages between 18 and 45 years, no use of illegal drugs, average alcohol consumption less than 15 glasses per week, cigarette consumption averages less than 20 cigarettes per day

Exclusion Criteria

  • Chronic pain conditions, acute pain in the last 4 weeks, open injuries, inflammation or skin infections, any long\-term medication, participation in another drug\-related study in the last 2 months, severe somatic, neurological or psychiatric illness, cancer, alcohol, medication or drug addiction, other serious health problems, current severe mental or physical exertion, hypersensitivity or intolerance to remifentanil, MRI\-specific exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials